RPS proposes restructure of executive team

A spokesperson for the Society has confirmed that two roles are at potential risk but no decisions or outcomes have been reached.
Royal Pharmaceutical Society headquarters on East Smithfield, east London

The Royal Pharmaceutical Society (RPS) is working on a proposal to change the structure of its executive team, in line with its five-year strategy announced in May 2021.

A spokesperson for the RPS told The Pharmaceutical Journal that two roles were potentially at risk of redundancy, but at this stage was not able to confirm who would be affected by the proposed changes.

The RPS strategy for 2021–2026 was launched in May 2021 and set out seven strategic goals to strengthen the viability and sustainability of the organisation, including shaping the future of pharmacy and medicines use, creating a “sense of belonging” and enhancing organisational effectiveness.

The spokesperson added: “[As part of this strategy], we are working on a proposal that could result in a change in the existing structure at executive level within the organisation and two roles have been identified at potential risk of redundancy.

“This is very much at proposal stage and no final decisions or outcomes have been reached,” they added.

“We are unable to go into the specifics of the process for individuals due to its confidential nature, but we will of course go through a fair, reasonable and confidential consultation process and are supporting the individuals involved. 

“No one should be in any doubt that our commitment to education and the profession’s development remains the highest priority for us, and equally support for our members, thought leadership and advocacy are core to what we do as a professional leadership body.”

Last updated
The Pharmaceutical Journal, PJ, March 2022, Vol 308, No 7959;308(7959)::DOI:10.1211/PJ.2022.1.132838

You may also be interested in